Is BOTRF or JNJ a better dividend investment in 2026?

BOTRF currently yields 4.35% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BOTRF offers higher current income.

What is the dividend yield difference between BOTRF and JNJ?

BOTRF has a forward dividend yield of 4.35% ($0.01/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.99 percentage points.

Home › Compare › BOTRF vs JNJ

BOTRF vs JNJ: Dividend Comparison 2026

BOTRF yields 4.35% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BOTRF wins by $2.72M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BOTRF

● Live price

4.35%

Share price

$0.23

Annual div

$0.01

5Y div CAGR

61.9%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.74M

Annual income

$2,009,336.21

Full BOTRF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BOTRF vs JNJ

📍 BOTRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BOTRF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BOTRF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BOTRF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOTRF

Annual income on $10K today (after 15% tax)

$369.57/yr

After 10yr DRIP, annual income (after tax)

$1,707,935.78/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, BOTRF beats the other by $1,707,232.17/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOTRF + JNJ for your $10,000?

BOTRF: 50%JNJ: 50%

100% JNJ50/50100% BOTRF

Portfolio after 10yr

$1.38M

Annual income

$1,005,081.99/yr

Blended yield

72.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BOTRF

No analyst data

Altman Z

0.8

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOTRF buys

JNJ buys

No recent congressional trades found for BOTRF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBOTRFJNJ

Forward yield	4.35% ✓	3.36%
Annual dividend / share	$0.01	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	61.9% ✓	5.8%
Portfolio after 10y	$2.74M	$20.0K ✓
Annual income after 10y	$2,009,336.21 ✓	$827.78
Total dividends collected	$2.65M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BOTRF vs JNJ ($10,000, DRIP)

Year	BOTRF Portfolio	BOTRF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,404	$703.91	$10,676	$355.77	+$728.00 → BOTRF
2	$13,417	$1,214.61	$11,407	$389.39	+$2.0K → BOTRF
3	$16,518	$2,162.19	$12,198	$426.53	+$4.3K → BOTRF
4	$21,702	$4,027.82	$13,056	$467.62	+$8.6K → BOTRF
5	$31,229	$8,007.12	$13,987	$513.12	+$17.2K → BOTRF
6	$50,848	$17,433.55	$14,998	$563.56	+$35.9K → BOTRF
7	$97,358	$42,950.86	$16,098	$619.52	+$81.3K → BOTRF
8	$228,606	$124,432.40	$17,295	$681.69	+$211.3K → BOTRF
9	$686,698	$442,090.10	$18,599	$750.82	+$668.1K → BOTRF
10	$2,744,103	$2,009,336.21	$20,022	$827.78	+$2.72M → BOTRF

BOTRF vs JNJ: Complete Analysis 2026

BOTRF — Stock

China Everbright Water Limited, an investment holding company, provides water environmental management services in Mainland China and Germany. The company is involved in waste water treatment and reusable water; river restoration work; leachate and waste water treatment, as well as construction and maintenance of pipeline network; research and development, and consulting on water environmental technologies and treatment technology; and construction and operation of wetland ecological engineering projects. It also engages in the provision of business development and management services; survey, mapping, design, and consultancy for municipal projects; solar energy business; sponge city construction, operation, and research and development; and supply, construction, and operation of water supply facilities, as well as waste water source heat pumps. As of December 31, 2021, it invested in and operated water treatment projects with a designed daily waste water treatment capacity of approximately 7 million m3. The company is based in Shenzhen, the People's Republic of China. China Everbright Water Limited is a subsidiary of China Everbright Water Holdings Limited.

Full BOTRF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BOTRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOTRF vs SCHD BOTRF vs JEPI BOTRF vs O BOTRF vs KO BOTRF vs MAIN BOTRF vs ABBV BOTRF vs MRK BOTRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.